COST-EFFECTIVENESS ANALYSIS OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG VERSUS TIOTROPIUM/OLODATEROL 5/5 MCG IN SYMPTOMATIC PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN

Simple item page
dc.contributor.authorDriessen, M.
dc.contributor.authorWhalen, J.
dc.contributor.authorBuguth, Seewoodharry B.
dc.contributor.authorVallejo-Aparicio, L. A.
dc.contributor.authorNaya, I
dc.contributor.authorAsukai, Y.
dc.contributor.authorAlcazar-Navarrete, B.
dc.contributor.authorMiravitlles, M.
dc.contributor.authorGarcia-Rio, F.
dc.contributor.authorRisebrough, N.
dc.contributor.authoraffiliation[Driessen, M.] GSK, Value Evidence & Outcomes, Brentford, Middx, England
dc.contributor.authoraffiliation[Asukai, Y.] GSK, Value Evidence & Outcomes, Brentford, Middx, England
dc.contributor.authoraffiliation[Whalen, J.] ICON Plc, ICON Hlth Econ, Abingdon, Oxon, England
dc.contributor.authoraffiliation[Buguth, Seewoodharry B.] ICON Plc, ICON Hlth Econ, Abingdon, Oxon, England
dc.contributor.authoraffiliation[Vallejo-Aparicio, L. A.] GSK, Dept Evaluac Medicamentos, Madrid, Spain
dc.contributor.authoraffiliation[Naya, I] GSK, Global Resp Franchise, Brentford, Middx, England
dc.contributor.authoraffiliation[Alcazar-Navarrete, B.] Hosp Alta Resoluc Loja, Granada, Spain
dc.contributor.authoraffiliation[Miravitlles, M.] Hosp Valle De Hebron, Barcelona, Spain
dc.contributor.authoraffiliation[Garcia-Rio, F.] Univ Autonoma Madrid, Hosp Univ La Paz, IdiPAZ, Madrid, Spain
dc.contributor.authoraffiliation[Risebrough, N.] ICON Plc, ICON Hlth Econ, Toronto, ON, Canada
dc.contributor.funderGlaxoSmithKline
dc.date.accessioned2025-01-07T12:39:59Z
dc.date.available2025-01-07T12:39:59Z
dc.date.issued2018-05-01
dc.identifier.doi10.1016/j.jval.2018.04.1583
dc.identifier.essn1524-4733
dc.identifier.issn1098-3015
dc.identifier.unpaywallURLhttp://www.valueinhealthjournal.com/article/S1098301518318898/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24828
dc.identifier.wosID438630000636
dc.issue.number1
dc.journal.titleValue in health
dc.journal.titleabbreviationValue health
dc.language.isoen
dc.organizationSAS - Hospital de Poniente
dc.page.numberS233-S233
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.titleCOST-EFFECTIVENESS ANALYSIS OF UMECLIDINIUM BROMIDE/VILANTEROL 62.5/25 MCG VERSUS TIOTROPIUM/OLODATEROL 5/5 MCG IN SYMPTOMATIC PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SPAIN
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number21
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital de Poniente

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía